Table 3.
Unadjusted and Adjusted regression and Time-to-Event analyses results between groups
| Variable | N | Control | N | APEP | N | Co-ef | Unadjusted | p | N | Adjusted | p |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LOS (bed nights) | 94 | 970 | 95 | 880 | 199 | HR | 1.09 (0.77–1.56) | 0.6 | 125 | 1.3 (0.9–1.87) | 0.16 |
| Steps median [IQR] | 23 | 597 [346–846] | 25 | 889 [575–1088] | 48 | β | 262.1 (−80–604) | 0.1 | 48 | 316 (−25–656) | 0.07 |
| SPPB Score Discharge m (±SD) | 89 | 3.7 (±2.1) | 86 | 4.6 (±2.5) | 178 | β | 0.88 (0.20–1.57) | 0.01 | 174 | 0.78 (0.28–1.29) | 0.003 |
| SPPB Score Follow-up m (±SD) | 52 | 4.7 (±2.53) | 72 | 5.12 (±2.38) | 123 | β | 0.45 (−0.43–1.33) | 0.3 | 122 | 0.67 (−0.74–0.87) | 0.87 |
| VAS SR Health Discharge m (±SD) | 89 | 62.4(±21.31) | 86 | 67.7 (±18.38) | 178 | β | 5.3 (−0.6–1.11) | 0.07 | 172 | 5.10 (− 0.78–10.98) | 0.9 |
| VAS SR Health Follow-up m (±SD) | 68 | 58.5 (±21.6) | 77 | 65.2 (±21.2) | 145 | β | 6.75 (0.3–13.8) | 0.05 | 143 | 0.26 (0.09–0.47) | 0.004 |
| READMISSION Follow-up | 94 | 16 (17%) | 95 | 30 (32%) | 176 | β | 2.2 (1.1–4.3) | 0.03 | 172 | 2.9 (1.18–5.2) | 0.01 |
| FALLS Follow-up | 68 | 18 (26%) | 77 | 12 (16%) | 189 | OR | 0.6 (0.26–1.36) | 0.2 | 184 | 0.57 (0.24–1.38) | 0.2 |
| DEATH Follow-up | 94 | 12 (19%) | 95 | 5 (5%) | 189 | OR | 0. 40 (0.13–1.16) | 0.08 | 184 | 0.38 (0.11–1.14) | 0.08 |
| IND Follow-up | 68 | 44 (65%) | 77 | 58 (75%) | 167 | OR | 1.68 (1. – 3.3) | 0.04 | 165 | 1.85 (0.82–3.6) | 0.05 |
| NEGATIVE EVENTS Follow-up | 94 | 38 (40%) | 95 | 18 (19%) | 189 | OR | 0.46 (0.23–0.92) | 0.03 | 184 | 0.43 (0.2–0.92) | 0.03 |
LOS and Steps multivariate models adjusted for age and frailty only
All other multivariable models adjusted for age, gender, frailty, fear of falling, physical performance on admission and the baseline score
Abbreviations and possible score ranges: LOS: length of stay (nights); Steps: average daily step-count; SPPB Score: Short Physical Performance Battery [a higher score reflects a better physical performance, range 0–12]; IND: ability to walk independently on level surfaces; VAS SR Health (EQ 5D5L): Visual Analogue Scale EuroQol 5-Domain 5-Level, [range 1–100]; READMISSION: medical readmissions